Home » Itamar Medical Corporate News

Itamar Medical Corporate News

Read and download below our recent news and media releases

5 Questions with Itamar Medical CEO Gilad Glick

Sleep Testing Is Evolving. How Will It Look In the Near Future?

Itamar™ Medical and BetterNight to Join Forces Offering Referred Patients Home Based Virtual-Care Sleep Solution for the Diagnosis and Treatment of Sleep Apnea

Itamar™ Medical Implements Broad Range of Actions in Response to COVID-19 Pandemic

Itamar™ Medical Reports Record Fourth Quarter and Full Year 2019 Revenues

Itamar™ Medical and Clalit Research Institute Establish Research Collaboration to Explore WatchPAT Signals’ Ability to Predict Health Outcomes Using Existing Big Data and Artificial Intelligence

Itamar™ Medical to Report Fourth Quarter and Full Year 2019 Financial Results and Host Conference Call on Tuesday, March 3, 2020

Itamar™ Medical Announces Publication of COMPASS Study Validating First Scoring Guidelines for WatchPAT®️ Device in Diagnosing Sleep Apnea

Itamar™ Medical Announces Closing of Upsized Public Offering of American Depositary Shares and Full Exercise of the Underwriters’ Option to Purchase Additional ADSs

Itamar^™ Medical Announces Upsizing and Pricing of Public Offering of American Depositary Shares

Itamar^™ Medical Announces Proposed $30 Million Offering of American Depositary Shares

Itamar^™ Medical Announces Preliminary Revenue for Fourth Quarter and Full Year 2019 and Revenue Guidance for Full Year 2020

Itamar Medical^™ Selected to Participate in the Prestigious Weizmann Institute Project 10K

Itamar^™ Medical and SoClean® Announce Collaboration to Offer WatchPAT^®️ ONE and other Digital Health Services Through Direct-to-Consumer Channels

Itamar^™ Medical reports record third quarter 2019 revenues

Itamar^™ Medical to Present at the Piper Jaffray 31st Annual Healthcare Conference on December 4, 2019

Itamar^™ Medical to Report Third Quarter 2019 Financial Results and Host Conference Call on Tuesday, November 26, 2019

ItamarTM Medical Announces Blue Shield of CA and Blue Cross Blue Shield Federal Employee Plan to Include WatchPATTM in Their Policies

Itamar^™ Medical Appoints Jennifer Cook, MD, FAHA, FACC, as Global Medical Director

Itamar^™ Medical Advances Simple, Accurate and Reliable Home Sleep Apnea

Itamar^™ Medical to Present at the Ladenburg Thalmann 2019 Healthcare Conference on September 24, 2019

Itamar^™ Medical Reports Record Second Quarter 2019 Revenues

Itamar^™ Medical to Report Second Quarter 2019 Financial Results and Host Conference Call on Wednesday, August 14, 2019

Itamar^™ Medical WatchPAT^®️ One 510k Clearance Final

Itamar^™ Medical reports first quarter 2019 financial results

Itamar^™ Medical Advances Simple, Accurate and Reliable Home Sleep Apnea Testing with Launch of WatchPAT^®️ 300

Itamar^™ Medical Reports Fourth Quarter And Full Year 2018 Financial Results With Record Revenues

Itamar^™ Medical to Present at the Oppenheimer 29th Annual Healthcare Conference on March 20, 2019

Itamar^™ Medical to Commence Trading on Nasdaq

Itamar^™ Medical Announces that Publication on the Role of Obstructive Sleep Apnea in Atrial Fibrillation Selected for Inclusion in Circulation’s 2018 Year in Review

Itamar^™ Medical Partners with CardioVisual to Educate Patients and Healthcare Providers on the Importance of Sleep Apnea Testing and Streamline Cardiology Practice Workflow

Itamar^™ Medical Announces Definitive Agreements for $11.5 Million Private Placement

Itamar^™ Medical Reports Record Third Quarter 2018 Financial Results

Itamar^™ Medical Reports Second Quarter 2018 Financial Results

Itamar^™ Medical Announces Favorable CMS Reimbursement Decision to its WatchPAT^®️ Sleep Apnea Testing Device

Itamar^®️ Medical reports record financial results for the first quarter, with 26% increase in revenue to $5.5 million and minimal operating loss

Itamar^™ Medical Launches SleePath^®️, an Integrated Cloud-based Sleep Apnea Patient Care Pathway Management Tool for AFib Patients at Heart Rhythm 2018

Itamar Medical Highlights New WatchPAT^®️ Scoring Guidelines Based on the COMPASS(1) Study Results from Johns Hopkins Sleep Investigators at SLEEP 2018

Itamar^™ Medical Reports Fourth Quarter and Full Year 2017 Financial Results, Record Revenue of Nearly $21 million in 2017, Significant Decrease in Operating Loss.

Airway Management announced a new partnership with Itamar^®️ Medical Ltd to distribute the myTAP oral appliance.

FDA clearance for the new WatchPAT^®️ Central Plus

Itamar^™ Medical BioTelemetry Collaboration

EndoPAT^®️ system may help measure cardiovascular risk from breast cancer treatment

Itamar^™ Medical Reports Success in Clinical Study Validating WatchPAT^®️ for Central Sleep Apnea Differentiation, Submits Application for FDA Clearance of New WatchPAT^®️ Version

ItamarTM Medical Offers a Total Sleep Apnea Management Solution to Cardiologists

New Agreement Puts Itamar^™ Medical Inc. and Arterial Health International (AHI)

Galmed Pharmaceuticals and Itamar^®️ Medical to Collaborate on Assessing Aramchol’s Effect on Endothelial Function.

Itamar^™ Medical Signs an Exclusive Distribution Agreement with Nihon Kohden Japan for Its EndoPAT Device

Itamar^™ Medical Launches WatchPAT^®️ Unified

Itamar^™ Launches New Cloud Service

Yelin Lapidot and Migdal Insurance to Invest NIS 23.6 Million in Itamar Medical in a Private Equity Placement New Agreement Puts Itamar^®️ Medical Inc. and Arterial Health International (AHI)